Damas, Alexander A.
HRN: 21-77-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/06/2024
02/12/2024
IV
500 Mg
Q8
Partial Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes